Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors
Clinical trial NCT03326973 · COMPLETED
Trial details
- NCT number
- NCT03326973
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-25
- Primary completion
- 2020-12-14
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.